Radioactive Iodine Treatment and External Radiotherapy for Lung and Bone Metastases from Thyroid Carcinoma

Journal of Nuclear Medicine

Volumn 37, Issue 4-6, 1996, Pages 598-605

  Schlumberger, Martin ^a   Challeton, Cécile ^a   De Vathaire, Florent ^a   Travagli, Jean Paul ^a   Gardet, Paule ^a   Lumbroso, Jean Denis ^a   Francese, Cecilia ^a   Fontaine, Françoise ^a   Ricard, Marcel ^a   Parmentier, Claude ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

External radiotherapy; Iodine 131; Metastases; Thyroid carcinoma

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BONE TUMOR; CHILD; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL; SURVIVAL RATE; THYROID TUMOR; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CARCINOMA, PAPILLARY; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; THYROGLOBULIN; THYROID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030119620     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Nemec JV, Zamrazil V, Pohunkova D, Rohling A Radioiodine treatment of pulmonary metastases of differentiated thyroid cancer: results and prognostic factors. Nuklearmedizin 1979,18:86-90.
2. Beierwaltes WH, Nishiyama RH, Thompson KW, et al. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med 1982;23:561-568.
3. Brown AP, Greening WP, McCready VR, et al. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984;57:523-527.
4. Massin JP, Savoie JC, Garnier H, et al. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 1984;53:982-992.
5. Samaan NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985;60:376-380.
6. Niederle B, Roka R, Schemper M, et al. Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results. Surgery 1986;100:1088-1097.
7. Schlumberger M, Tubiana M, De Vathaire F, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol. Metab 1986;63:960-967.
8. Hoie J, Stenwig AE, Kullmann G, Lindegaard M. Distant metastases in papillary thyroid cancer. A review of 91 patients. Cancer 1988;61:1-6.
9. Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-508.
10. Marcocci C, Pacini F, Elisei R, et al. Clinical and biological behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989;106:960-966.
11. Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993;34:1626-1631.
12. Coliez R, Tubiana M, Sung S. Disparition des métastases pulmonaires d'un cancer thyroïdien sous l'influence de l'iode radioactif. J Radiol Electrol (Paris) 1951;32:396-398.
13. Tubiana M, Lacour J, Monnier JP, et al. External radiotherapy and radioiodine in the treatment of 359 thyroid cancers. Br J Radiol 1975;48:894-907.
14. Charbord P, L'Heritier C, Cukersztein W, et al. Radioiodine treatment in differentiated thyroid carcinomas. Treatment of first local recurrences and of bone and lung metastases. Ann Radiol (Paris) 1977;20:783-786.
15. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989;63:908-921.
16. Tubiana M, Schlumberger M, Rougier PH, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
17. Tubiana M, Haddad E, Schlumberger M, et al. External radiotherapy in thyroid cancers Cancer 1985;55:2062-2071.
18. Schlumberger M, Charbord P, Fragu P, et al. Relationship between thyrotropin stimulation and radioiodine uptake in lung metastases of differentiated thyroid carcinoma. J Clin Endocrinol Metab 1983;57:148-151.
19. 131I scans in the follow-up of thyroid cancer patients. In: Hamburger JI, ed. Diagnostic methods in clinical thyroidology. New York: Springer-Verlag; 1989:147-157.
20. Schlumberger M, Fragu P, Gardet P, et al. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients. Eur J Nucl Med 1991,18:153-157.
21. Schlumberger M. Follow-up of patients with differentiated thyroid carcinoma. In: Johnson JT, Didolkar MS, eds. Head and neck cancer. Amsterdam: Elsevier Science Publishers BV; 3;1993:903-910.
22. Felson B. The interstitium. In: Felson B, ed. Chest Roentgenology, Philadelphia; W.B. Saunders Company; 1973:314-319.
23. Schlumberger M, Arcangioli O, Piekarski JD, et al. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-ray. J Nucl Med 1988;29:1790-1794.
24. Droz JP, Schlumberger M, Rougier P, et al. Chemotherapy in metastatic non anaplastic thyroid cancer: experience at the Institut Gustave-Roussy. Tumori 1990;76:480-483.
25. Cox DR. Regression models and life tables. JR Stat Soc (B) 1972;34:187-220.
26. Benhamou E, Laplanche A, Wartelle M. Incidence des cancers en France: 1978-1982. Les Editions de l'Inserm, Paris, 1990.
27. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality International Agency for Research on Cancer, Lyon, 1993.
28. Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28:1888-1891.
29. Anderson JR, Cam KC, Gelber RD Analysis of survival by tumor response. J Clin Oncol 1983;11:710-719.
30. Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. New Engl J Med 1983;309: 937-941.
31. Maxon HR, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990;19:685-718.
32. Pineda JD, Lee T, Ain K, et al. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scans J Clin Endocrinol Metab 1995;80:1488-1492.
33. Hall P, Holm LE, Lundell G, et al. Cancer risks in thyroid cancer patients. Br J Cancer 1991;64:159-163